...
首页> 外文期刊>Urologic oncology >Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.
【24h】

Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.

机译:原发性膀胱腺癌的长期结果:192例患者的报告。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: To evaluate the clinical presentation and treatment end results of primary adenocarcinoma of the urinary bladder, and to determine the significant independent prognostic factors that determine this outcome. PATIENTS AND METHODS: Of 3659 patients who underwent cystectomy, 192 had adenocarcinoma of the urinary bladder, with a relative frequency of 5.2%. Most of these patients (68.2%) presented in late stages (P3 + P4). The incidence of pelvic lymph nodes involvement was 25.5%. Mucinous adenocarcinoma was reported in 28 patients (14.6%), papillary in 20 (10.4%), signet ring in 14 (7.3%), while not otherwise specified was reported in 130 (67.7%) in the cystectomy specimens. RESULTS: Mucinous and signet-ring histologic subtypes showed increased frequency of high stages and high grades, and more nodal involvement than the papillary and not otherwise specified. All patients were treated with radical cystectomy and pelvic lymphadenectomy with (69 patients) or without (123) postoperative radiotherapy. The 5-year disease-free survival rate was 46 +/- 4% for all patients with adenocarcinoma. Postoperative radiotherapy improved the disease-free survival significantly. The 5-year disease-free survival rate for the postoperative radiotherapy group was 61 +/- 6% compared to 37 +/- 5% for the cystectomy alone group (P = 0.002). Local control rate was significantly improved from 53 +/- 7% for cystectomy alone to 96 +/- 3% for postoperative radiotherapy patients (P = 0.00001). Distant metastases were the leading cause of death in the postoperative radiotherapy group. CONCLUSIONS: Within the limitations provided by retrospective studies, it could be concluded that postoperative radiotherapy improved the disease-free survival through its effect on local control. The disease-free survival independent prognostic variables were tumor stage, postoperative radiotherapy, nodal involvement, and adenocarcinoma subclassification. These factors, except the adeno-subclassification, were also found to determine thelocal control rate. On the other hand, the independent prognostic factors for distant metastasis were lymph nodal involvement, stage, and adeno-subclassification.
机译:目的:评估原发性膀胱腺癌的临床表现和治疗最终结果,并确定决定这一结果的重要独立预后因素。患者与方法:在3659例行膀胱切除术的患者中,有192例患有膀胱腺癌,相对频率为5.2%。这些患者大多数(68.2%)出现在晚期(P3 + P4)。盆腔淋巴结受累的发生率为25.5%。在膀胱切除术标本中,有28例(14.6%)粘液性腺癌,20例(10.4%)乳头状癌,14例(7.3%)有印戒,另有130例(67.7%)没有特别报道。结果:粘液和印戒组织学亚型显示高分期和高分期的发生率增加,并且淋巴结受累比乳头状多,并且没有其他规定。所有患者均接受了根治性膀胱切除术和盆腔淋巴结清扫术(69例)或不进行(123)术后放疗。所有腺癌患者的5年无病生存率为46 +/- 4%。术后放疗显着改善了无病生存期。术后放疗组的5年无病生存率为61 +/- 6%,而单独进行膀胱切除术的组为37 +/- 5%(P = 0.002)。局部控制率从单纯膀胱切除术的53 +/- 7%显着提高到术后放疗患者的96 +/- 3%(P = 0.00001)。术后放疗组中远处转移是死亡的主要原因。结论:在回顾性研究提供的限制内,可以得出结论,术后放疗通过其对局部控制的作用改善了无病生存期。无病生存独立预后变量为肿瘤分期,术后放疗,淋巴结转移和腺癌亚分类。还发现这些因素,除了腺的亚分类外,还决定了局部控制率。另一方面,远处转移的独立预后因素是淋巴结转移,分期和腺亚分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号